Video

Julie Nangia Discusses the Impact of Hair Loss

Author(s):

Julie Nangia, M.D.

Julia Nangia, M.D., assistant professor at Baylor College of Medicine, discusses the impact that chemotherapy-related hair loss can have on patients with breast cancer.

Julia Nangia, M.D., assistant professor at Baylor College of Medicine, discusses the impact that chemotherapy-related hair loss can have on patients with breast cancer.

When a woman loses her hair, that may not be all that is lost. Hair loss also causes a loss of anonymity that a person is sick. But luckily, hair-preserving cooling caps are becoming more common for patients with cancer.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Image of man with text.
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses
Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.
Image of man with text.
Image of women, with text.
Image of Dr. with text.
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Related Content
Image of women.
July 10th 2025

Diagnosis Day: What I Felt, What I Learned

Patti McGee
I found a lump and was shocked to learn it was breast cancer, but over 22 years I’ve learned healing takes time, asking for help is strength, and hope grows.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Experts discuss treatment options for those with ER-positive, HER2-negative stage 4 breast cancer: © stock.adobe.com.
July 9th 2025

Understanding Therapeutic Options for ER+/HER2- Metastatic Breast Cancer

Kristie L. Kahl
Dr. Alicia Arnold and Dr. Priyanka Raval discuss first- and later-line treatment options for those with ER-positive, HER2-negative stage 4 breast cancer.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Laura Yeager is a two-time breast cancer survivor. Catch up on all of Laura's blogs here!
July 8th 2025

Dealing With the Unpredictability of Cancer

Laura Yeager
My cancer journey taught me that nothing is certain; however, with support, humor and acceptance, we can weather the ups and downs.
In a phase 2 study, 52% of patients treated with Bria-IMT plus a checkpoint inhibitor for metastatic breast cancer were alive at one year: © stock.adobe.com.
July 8th 2025

Bria-IMT Combo Shows Survival in Phase 2 Breast Cancer Trial

Spencer Feldman
In a phase 2 study, 52% of patients treated with Bria-IMT plus a checkpoint inhibitor for metastatic breast cancer were alive at one year.